CA1228301A - Method and composition for treating neurological disorders and aging - Google Patents

Method and composition for treating neurological disorders and aging

Info

Publication number
CA1228301A
CA1228301A CA000454518A CA454518A CA1228301A CA 1228301 A CA1228301 A CA 1228301A CA 000454518 A CA000454518 A CA 000454518A CA 454518 A CA454518 A CA 454518A CA 1228301 A CA1228301 A CA 1228301A
Authority
CA
Canada
Prior art keywords
choline
composition
precursor
amino acid
neurons
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA000454518A
Other languages
English (en)
French (fr)
Inventor
Richard J. Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Application granted granted Critical
Publication of CA1228301A publication Critical patent/CA1228301A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000454518A 1983-05-16 1984-05-16 Method and composition for treating neurological disorders and aging Expired CA1228301A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49520283A 1983-05-16 1983-05-16
US495,202 1983-05-16

Publications (1)

Publication Number Publication Date
CA1228301A true CA1228301A (en) 1987-10-20

Family

ID=23967687

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000454518A Expired CA1228301A (en) 1983-05-16 1984-05-16 Method and composition for treating neurological disorders and aging

Country Status (8)

Country Link
EP (1) EP0125900B1 (cg-RX-API-DMAC7.html)
JP (1) JPS60214734A (cg-RX-API-DMAC7.html)
AT (1) ATE45672T1 (cg-RX-API-DMAC7.html)
CA (1) CA1228301A (cg-RX-API-DMAC7.html)
DE (1) DE3479477D1 (cg-RX-API-DMAC7.html)
ES (1) ES8602409A1 (cg-RX-API-DMAC7.html)
GR (1) GR79973B (cg-RX-API-DMAC7.html)
IL (1) IL71819A (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2657013B1 (fr) * 1990-01-18 1992-05-15 Medgenix Group Sa Composition dietetique a base de polypeptides et acides amines.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1114295A (en) * 1977-11-02 1981-12-15 John H. Growdon Process and composition for treating disorders by administering choline or a compound that dissociates to choline
DE2967257D1 (en) * 1978-04-24 1984-11-22 Massachusetts Inst Technology Composition for regulating dopamine or norepinephrine levels in neuronal synapses
DE2962429D1 (en) * 1978-04-24 1982-05-19 Massachusetts Inst Technology A pharmaceutical composition comprising an amino acid for reducing blood serum prolactin levels
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
JPS5566512A (en) * 1978-11-15 1980-05-20 Massachusetts Inst Technology Method and composition for treating difficulties by administration of choline or choline dissociating compound
US4221784A (en) * 1979-04-05 1980-09-09 Massachusetts Institute Of Technology Process and composition for treating disorders by administering lecithin
DE2915433A1 (de) * 1979-04-17 1980-10-30 Christensen Plantorgan Werk Verwendung von physiologisch vertraeglichen methyldonatoren
US4397866A (en) * 1979-05-07 1983-08-09 Massachusetts Institute Of Technology Process for increasing glycine levels in the brain and spinal cord

Also Published As

Publication number Publication date
EP0125900A1 (en) 1984-11-21
DE3479477D1 (en) 1989-09-28
IL71819A0 (en) 1984-09-30
JPH0141124B2 (cg-RX-API-DMAC7.html) 1989-09-04
IL71819A (en) 1987-12-31
ES532873A0 (es) 1985-12-16
ES8602409A1 (es) 1985-12-16
EP0125900B1 (en) 1989-08-23
JPS60214734A (ja) 1985-10-28
GR79973B (cg-RX-API-DMAC7.html) 1984-10-31
ATE45672T1 (de) 1989-09-15

Similar Documents

Publication Publication Date Title
US4351831A (en) Process and composition for treating disorders by administering isoxsurpine and choline
US5006526A (en) Method of treating a vertebrate animal to reduce plasma triglycerides and cholesterol levels and to alleviate and prevent atherosclerosis
JP2588686B2 (ja) 高脂血症及び動脈硬化症の予防・治療薬
US4636494A (en) Process and composition for treating disorders by administering amphetamine and choline
MXPA02010668A (es) Analogos de gabapentina para alteraciones del sueno.
US10166252B2 (en) Method for assessing and treating or preventing impaired plasma polar lipid levels
US9216160B2 (en) Choline composition
US4624852A (en) Process and composition for treating neurological disorders and aging
US4775665A (en) Method and composition for treating neurological disorders and aging
US4397866A (en) Process for increasing glycine levels in the brain and spinal cord
DE69806788T2 (de) Zusammensetzung zur unterdrückung von entzugssymptomen und alkoholabhängigkeit bei alkoholikern sowie prävention von alkoholmissbrauch bei gesunden personen
US4346085A (en) Process and composition for treating disorders by administering amphetamine and choline
US4737489A (en) Method and composition for treating neurological disorders and aging
US4346084A (en) Process and composition for treating disorders by administering lithium and choline
US4626527A (en) Process for utilizing choline to sustain muscular performance
US4058601A (en) Method for treating alcoholism
EP0125900B1 (en) A pharmaceutical composition for use in treating neurological disease or aging
US20220143078A1 (en) Combination of Silicon and Magnesium for the Prevention and Treatment of Muscle Cramps
US4430330A (en) Process and composition for treating disorders by administering a phenothiazine and choline
US4405629A (en) Process for increasing glycine levels in the brain and spinal cord
US4456598A (en) Process and composition for treating disorders by administering a butyrophenone and a choline
WO2005123097A1 (en) Pyrimidines, such as cytidine, in treatments for patients with bipolar disorder
JP2004067537A (ja) 交感神経の興奮抑制剤
JPH0645539B2 (ja) 鎮痛剤
JPS6358809B2 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
MKEX Expiry